VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
Apr 28, 2015 – Oct 2, 2026, Dividends reinvested
- Final balance
- $37,425
- CAGR
- +12.24%
- Max drawdown
- −90.41%
- Sharpe ratio
- 0.53
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −10.63%
- 3M
- −20.03%
- 6M
- −13.97%
- YTD
- −14.89%
- 1Y
- +7.39%
- 3Y
- +40.18%
- 5Y
- +37.28%
- 10Y
- +35.83%
- Since 2015
- +12.24%
Metrics
Since 2015| Volatility | 101.34% |
|---|---|
| Sortino ratio | 1.08 |
| Calmar ratio | 0.14 |
| Best year, 2017 | +241.18% |
| Worst year, 2016 | −65.10% |
| Positive years | 6 of 10 |
| Longest drawdown | 4.6 years |
Worst drawdowns
Since 2015| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −90.4% | May 2015 | Aug 2017 | May 2018 | 3.1 years |
| −89.3% | Sep 2018 | Jun 2022 | Apr 2023 | 4.6 years |
| −78.9% | Feb 2024 | Apr 2025 | Not yet | 2.6 years so far |
| −62.7% | Jun 2023 | Oct 2023 | Feb 2024 | 8 months |
| −25.5% | Jun 2018 | Jun 2018 | Aug 2018 | 2 months |
Annual returns
2015 from Apr 28 · 2026 through Oct 2